acquires - International Biopharmaceutical Industry

Current Edition

news

Daiichi acquires another ADC drug through Glycotope licensing deal

Daiichi Sankyo is bringing a seventh antibody-drug conjugate, or ADC, into its pipeline through a licensing agreement with German biotech Glycotope. Specific fin...

31 July 2018 news acquires | ADC

Continue Reading →

news

Esco Group acquires AT Medical UAB

Esco Group to acquire AT Medical UAB, an Esco Ventures portfolio company, to accelerate development of the Esco life sciences ecosystem and delivery of innovative fe...

15 June 2018 news acquires | AT

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

Daiichi acquires another ADC drug through Glycotope licensing deal

Esco Group acquires AT Medical UAB

International Biopharmaceutical Industry